Babylon (NYSE:BBLN – Get Rating) was downgraded by stock analysts at BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Thursday, Marketbeat.com reports.
Separately, Citigroup reduced their price target on Babylon from $15.00 to $11.00 in a research report on Friday, March 10th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $53.08.
Babylon Price Performance
NYSE:BBLN opened at $5.89 on Thursday. The company has a market capitalization of $12.63 million, a P/E ratio of -0.22 and a beta of 2.57. Babylon has a 1 year low of $5.75 and a 1 year high of $120.75. The business has a fifty day simple moving average of $10.13 and a two-hundred day simple moving average of $11.64.
Hedge Funds Weigh In On Babylon
Babylon Company Profile
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally.
- Get a free copy of the StockNews.com research report on Babylon (BBLN)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with MarketBeat.com's FREE daily email newsletter.